New Prostate Cancer Cases per 100,000 Population (Males) by Year, New Mexico and U.S., 2000 to 2015

Why Is This Important?

In New Mexico, prostate cancer is the most commonly diagnosed cancer for African American, Asian, Hispanic and White men, and is the second most commonly diagnosed cancer for American Indian men. Prostate cancer is the leading cause of death from cancer for American Indian men, the second leading cause of death from cancer for African American and White men, and is the third leading cause of cancer death for Asian and Hispanic men in New Mexico.

Definition

New cases of prostate cancer per 100,000 population (males) in New Mexico Prostate cancer incidence is defined as new cases of malignant cancer of the prostate.

Data Notes

Data Sources

• New Mexico Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program.
  (http://gps.unm.edu/)
• New Mexico Tumor Registry
  (https://nmtrweb.unm.edu/)

How the Measure is Calculated

Data Issues

• New Mexico Population Estimates

  All population estimates apply to July 1 of the selected year. These estimates are considered the most accurate estimates for the state of New Mexico and should match those found on the University of New Mexico Geospatial and Population Studies website. Estimates include decimal fractions. Census tract population estimates were summed to produce County and Small Area population estimates. Population estimate totals may vary due to rounding. Population estimates for previous years are occasionally revised as new information becomes available. When publishing trend data, always be sure that your rates for earlier years match current rates on NM-IBIS that have been calculated with the most up-to-date population estimates.

• New Mexico Tumor Registry

  In agreement with the New Mexico Tumor Registry, to ensure confidentiality the count of cancer cases is suppressed for any given county if the count is between one and four and the population is less than 1,000. NOTE: The COVID-19 pandemic disrupted health services, leading to delays and reductions in cancer screening, diagnosis, and reporting to some central cancer registries. This may have contributed to an observed decline in 2020 incidence for most cancer sites.

Health Topic Pages Related to: Cancer Incidence - Prostate Cancer

• Cancer